It has been reported that tamoxifen treatment up-regulates HER2 by 40% in breast cancer cells expressing both HER2 and ER [82], and that when HER2 is co-expressed with ERa, the patients show a shorter disease-free survival and overall survival [83]. The gene discussed is ERBB2; the disease is breast cancer.